Evidence map›Paper›PMID 35134850›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2022

Current Antiretroviral Treatment Among People With Human Immunodeficiency Virus in the United States: Findings from the Centers for AIDS Research Network of Integrated Clinic Systems Cohort.

Jimmy Ma, Robin M Nance, Joseph A C Delaney, Bridget M Whitney, Laura Bamford, Ronnie M Gravett, Richard D Moore, Sonia Napravnik, Kenneth H Mayer, Jeffrey M Jacobson and 9 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Observational
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Jimmy MaDepartment of Medicine, University of Washington, Seattle, Washington, USA.ORCID 0000-0002-6849-3206
Robin M NanceDepartment of Medicine, University of Washington, Seattle, Washington, USA.
Joseph A C DelaneyCollege of Pharmacy, University of Manitoba, Winnipeg, Manitoba, Canada.
Bridget M WhitneyDepartment of Medicine, University of Washington, Seattle, Washington, USA.
Laura BamfordDepartment of Medicine, University of California, San Diego, California, USA.
Ronnie M GravettDepartment of Medicine, University of Alabama, Birmingham, Alabama, USA.
Richard D MooreDepartment of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
Sonia NapravnikDepartment of Medicine, University of North Carolina, Chapel Hill, North Carolina, USA.
Kenneth H MayerFenway Health Institute and Harvard Medical School, Boston, Massachusetts, USA.
Jeffrey M JacobsonDepartment of Medicine, Case Western Reserve University, Cleveland, Ohio, USA.
Katerina ChristopoulosDepartment of Medicine, University of California, San Francisco, California, USA.
Greer A BurkholderDepartment of Medicine, University of Alabama, Birmingham, Alabama, USA.
Jeanne KerulyDepartment of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
Joseph J EronDepartment of Medicine, University of North Carolina, Chapel Hill, North Carolina, USA.
Jeffrey MartinDepartment of Epidemiology and Biostatistics, University of California, San Francisco, California, USA.
Edward R CachayDepartment of Medicine, University of California, San Diego, California, USA.
Michael S SaagDepartment of Medicine, University of Alabama, Birmingham, Alabama, USA.
Heidi M CraneDepartment of Medicine, University of Washington, Seattle, Washington, USA.
Mari M KitahataDepartment of Medicine, University of Washington, Seattle, Washington, USA.

Funding

University of Washington/Fred Hutch Center for AIDS ResearchP30AI027757 · NIAID · UNIVERSITY OF WASHINGTON · PI EDWIN ROBERTO ORELLANA · 1988 to 2026
$104.9M
Unsolicited R24 for the CFAR-Network of Integrated Clinical Sciences, CNICSR24AI067039 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Michael S. Saag · 2006 to 2026
$99.4M
A-Z Clinical Trials UnitUM1AI069452 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Paul A. Goepfert · 2012 to 2026
$28.8M
HOST DEFENSE TRAINING IN ALLERGY AND INFECTIOUS DISEASEST32AI007044 · NIAID · UNIVERSITY OF WASHINGTON · PI DAVID Neal FREDRICKS · 1985 to 2026
$14.6M
NIAID NIH HHS P30 AI027757NIAID NIH HHS R24 AI067039NIAID NIH HHS T32 AI007044NIAID NIH HHS UM1 AI069452NIH HHS T32 AI704446
6 · The paper itself

Abstract

Among 14 049 people with human immunodeficiency virus in care in 2019-2020, 96% were treated with antiretroviral therapy (ART). Current antiretroviral treatment patterns highlight high uptake of guideline-recommended ART regimens including second-generation integrase strand transfer inhibitors (dolutegravir and bictegravir) and tenofovir alafenamide, especially in antiretroviral-naive individuals initiating ART.

Indexed as

Acquired Immunodeficiency SyndromeAnti-HIV AgentsHIV InfectionsAlanineAnti-Retroviral AgentsEmtricitabineHeterocyclic Compounds, 3-RingHIVHumansTenofovirUnited StatesAlanineAnti-HIV AgentsAnti-Retroviral AgentsEmtricitabineHeterocyclic Compounds, 3-RingTenofovirART guidelinesART treatment trendsART utilizationintegrase inhibitortenofovir alafenamide

Identifiers

PMID35134850
PMCPMC9464068

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.